GENinCode (LON:GENI) Trading Up 2.9% – Should You Buy?

GENinCode Plc (LON:GENI)’s stock price traded up 2.9% during trading on Thursday . The company traded as high as GBX 4 ($0.05) and last traded at GBX 3.91 ($0.05). 54,995 shares changed hands during trading, a decline of 72% from the average session volume of 193,609 shares. The stock had previously closed at GBX 3.80 ($0.05).

GENinCode Stock Up 2.4 %

The company’s fifty day simple moving average is GBX 4.05 and its 200-day simple moving average is GBX 5.56. The firm has a market capitalization of £6.88 million, a PE ratio of -77.80 and a beta of 0.66. The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89.

GENinCode Company Profile

GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.